Theranostics
Theranostics is a journal that publishes research articles in the field of vitro diagnostics, prognostics, and molecular therapeutics.
Raised 1M EQUITY on November 3, 2014
About
Theranostics is a personalized medicine company that develops assays to measure activation of signaling pathways for molecular targeted therapies and companion diagnostics.
Mission
Theranostics develops methods to measure activation of signaling pathways required for molecular targeted therapies and companion diagnostics, operating in the personalized medicine space. The company is based in Philadelphia. A regulatory filing indicates Theranostics is raising $1 million in equity. On Oct. 27 the company appointed Luis T. Gutierrez as president and CEO. Gutierrez joins from a VP role at clinical research organization Aptiv Solutions. The article does not provide revenue, user metrics, or additional financial details.
Quick Facts
Founded
2011
Funding
EQUITY
Industry
Analytics, Journalism, Medical, Publishing
Team Size
11-50
Headquarters
Sydney, New South Wales, Australia
Careers
View Careers Page
Theranostics
https://jobs.ashbyhq.com/thnoNo open roles at this time.
Check their careers page for updates